Product details

President of the Division needs to assess global strategy based upon a thorough analysis of the industry, competitors, and competing brands. Information to the background are contained in ''Note on the World OTC Drug Industry'' (IMD-3-0711), ''Competitors in the OTC Drug Industry'' (IMD- 3-0712) and ''Winning and Losing Brands in the OTC Drug Industry'' (IMD-5- 0510). This case allows students to assess how to bring division into compliance with their views on global strategy and global marketing. Allows for a discussion if this industry is best tackled with a multi- domestic marketing approach or if there are sufficient commonalties to allow a partial or fully integrated global marketing strategy.